Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| THRESHOLD PHARMACEUTICALS INC | 4,198,535 | reported | 25 Nov 2019 | tx 1+937,000 |
| Inozyme Pharma, Inc. | 4,174,379 | reported | 19 Apr 2022 | tx 1+1,355,000 |
| ProNAi Therapeutics Inc | 5,611 | reported | 27 Apr 2022 | tx 8+16,030−2,139,771 |
| Talaris Therapeutics, Inc. | 0 | reported | 11 May 2021 | tx 5+3,220,775−2,985,775 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 2,152 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 5,023 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 7,175 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 175,000 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 252 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 840 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 588 | 0.00 USD | |
| 27 Apr 2022 | OTHER | ProNAi Therapeutics Inc | 1,964,771 | 0.00 USD | |
| 19 Apr 2022 | PURCHASE | Inozyme Pharma, Inc. | 1,355,000 | 3.69 USD | |
| 11 May 2021 | CONVERSION | Talaris Therapeutics, Inc. | 2,985,775 | — | |
| 11 May 2021 | PURCHASE | Talaris Therapeutics, Inc. | 235,000 | 17.00 USD | first after silence |
| 11 May 2021 | CONVERSION | Talaris Therapeutics, Inc. | 406,338 | 0.00 USD | deriv |
| 11 May 2021 | CONVERSION | Talaris Therapeutics, Inc. | 1,308,410 | 0.00 USD | deriv |
| 11 May 2021 | CONVERSION | Talaris Therapeutics, Inc. | 1,271,027 | 0.00 USD | deriv |
| 25 Nov 2019 | PURCHASE | THRESHOLD PHARMACEUTICALS INC | 937,000 | 8.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 11 May 2021.